Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.7.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-Based Compensation Expense

Total stock-based compensation expense consists of the following:

 

     Years Ended 31 March  
(Millions of US dollars)    2017      2016      2015  

Liability Awards Expense

     $ 5.4        $ 4.8      $ 3.3  

Equity Awards Expense

     9.3        10.3        9.2  
  

 

 

 

Total stock-based compensation expense

     $     14.7        $     15.1      $     12.5  
  

 

 

 
Summary of Stock Options Available for Grant

The following table summarizes the Company’s shares available for grant as options, restricted stock units or other equity instruments under the LTIP and 2001 Plan at 31 March 2017, 2016 and 2015:

 

     Shares
Available for
Grant
 

Balance at 31 March 2015

         24,754,902     
  

 

 

 

Granted

     (1,410,560)    

New Shares Authorized

     5,000,000     

Forfeitures Available for Re-grant

     74,466     
  

 

 

 

Balance at 31 March 2016

     28,418,808     
  

 

 

 

Granted

     (1,179,994)    
  

 

 

 

Balance at 31 March 2017

     27,238,814     
  

 

 

 
Summary of Stock Options Activity

The following table summarizes the Company’s stock options activity during the noted period:

 

     Outstanding Options      
     Number      Weighted
Average
Exercise
Price (A$)
 

Balance at 31 March 2015

          511,780           8.17  
  

 

 

    

Exercised

     (333,287)          8.54  

Forfeited

     (74,466)          7.85  
  

 

 

    

Balance at 31 March 2016

     104,027           7.22  
  

 

 

    

Exercised

     (55,131)          7.97  
  

 

 

    

Balance at 31 March 2017

     48,896           6.38  
  

 

 

    
Outstanding and Exercisable Options under 2001 Equity Incentive Plan and Long-Term Incentive Plan

The following table summarizes outstanding and exercisable options under both the 2001 Plan and the LTIP as of 31 March 2017:

 

     Options Outstanding and Exercisable

  Exercise  

  Price (A$)  

   Number    Weighted
Average
Remaining
Life (in Years)
   Weighted
Average
Exercise
Price (A$)
   Aggregate
Intrinsic
Value (A$)

    6.38    

       48,896     0.7    6.38        693,834 

Restricted Stock Unit Activity

The following table summarizes the Company’s restricted stock unit activity during the noted period:

 

     Restricted
Stock Units
     Weighted
Average Fair
Value at Grant
Date (A$)
 

Non-vested at 31 March 2015

         4,008,001           8.44  
  

 

 

    

Granted

     1,410,560           14.95  

Vested

     (1,219,352)          7.28  

Forfeited

     (149,755)          9.92  
  

 

 

    

Non-vested at 31 March 2016

     4,049,454           11.00  
  

 

 

    

Granted

     1,179,994           18.54  

Vested

     (1,314,825)          8.60  

Forfeited

     (574,378)          9.10  
  

 

 

    

Non-vested at 31 March 2017

     3,340,245           14.80  
  

 

 

    
Assumptions Used for Restricted Stock Grants

The following table includes the assumptions used for restricted stock grants (market condition) valued during the year ended 31 March 2017 and 2016, respectively:

 

Vesting Condition:    Market      Market  
    

FY17

    

FY16

 

Date of grant

     16 Sep 2016        16 Sep 2015  

Dividend yield (per annum)

     2.3%        3.8%  

Expected volatility

     31.5%        36.8%  

Risk free interest rate

     1.1%        1.5%  

Expected life in years

     3.0        3.0  

JHX stock price at grant date (A$)

     20.82        17.76  

Number of restricted stock units

     456,819        579,262